Platform or Procedure: How a Surgical Robotics Company Used Market Research and Strategy Advisory to Resolve Its Most Consequential Product Strategy Decision
Executive Snapshot
Client
Situation/Challenge
Objective
Constancy Researchers Solution
Impact
Client Outcome
The Situation / Challenge
Surgical robotics occupies a distinctive position in medical capital equipment, where the purchasing decision is shaped by hospital capital committees, surgical chiefs, and the clinical evidence base supporting specific procedures. A platform performing capably across many procedures offers commercial breadth, but purchasing committees increasingly evaluate systems against depth of evidence in the procedures their surgeons actually perform.
The client had built a general-purpose platform with genuine capability across several specialties, but leadership was divided on where to direct the next phase of investment. The engineering team argued for continued versatility, citing hospital systems that valued one platform across departments. The clinical and commercial team argued for concentrated investment in two or three procedures where deeper evidence could create real differentiation.
Both sets of customer conversations were real, but neither side had the structured, market-wide evidence needed to determine which purchasing logic actually predominated, and the disagreement had begun slowing concrete investment decisions.
Key Challenges
- No structured, procedure-category-level view of competitive density across the market, leaving the platform-versus-procedure debate without an objective foundation
- No systematic research into how hospital capital committees actually weighted platform breadth against procedure-specific clinical evidence in purchasing decisions
- Conflicting customer conversation evidence cited by different internal teams, with no way to determine which was more representative of the broader market
- No competitive mapping identifying which procedure categories had entrenched, well-evidenced robotic competitors versus which remained genuinely open to entry
- A leadership disagreement delaying clinical trial design and regulatory submission planning
- Board expectation that the investment question be resolved with independent market evidence rather than continued internal advocacy from either team
In surgical robotics, the platform-versus-procedure-specific question is rarely about which approach is correct in the abstract — it is about where a concentrated clinical evidence investment can create differentiation a broader platform cannot.
Constancy Researchers Solution
Constancy Researchers approached the engagement recognising that the disagreement reflected two genuinely different hospital purchasing behaviours that needed measuring at the market level rather than argued through individual customer anecdotes.
Global Surgical Robots Market Sizing & Procedure Category Analysis
- Delivered a market research report sizing the global surgical robotics market by procedure category, geography, and hospital system type, with five-year forecasts distinguishing established categories from emerging ones.
- Identified that procedure categories with two or more established robotic competitors showed meaningfully slower new-entrant success, directly informing where concentrated investment was likely to succeed.
Hospital Purchasing Committee Decision Criteria Research
- Researched the actual weighting hospital capital committees applied to platform breadth versus procedure-specific evidence, segmented by system size and academic versus community status.
- Found that larger academic systems weighted procedure-specific evidence more heavily than platform breadth, while smaller community systems valued a single multi-department platform — a segmentation neither internal team had considered.
Competitive Density & White Space Mapping by Procedure Category
- Mapped competitive density across all major procedure categories where robotic systems were in use or development, identifying which had entrenched incumbents and which remained genuinely accessible.
- Identified two procedure categories combining strong demand growth, an absence of entrenched competitors with strong evidence, and alignment with the client’s existing platform.
Reimbursement & Regulatory Pathway Research
- Researched reimbursement and regulatory pathway complexity for the two identified categories, assessing realistic timelines for generating the clinical evidence base needed.
- Confirmed that both categories had reimbursement pathways already established for robotic-assisted procedures, removing a major source of internal uncertainty.
Resolved Investment Strategy & Commercial Roadmap
- Synthesised findings into a resolved investment strategy, concentrating clinical and regulatory investment in the two identified categories while preserving the platform’s broader capability as a long-term asset.
- Delivered a board-ready roadmap covering clinical trial design, regulatory submission sequencing, and a commercial plan differentiated by hospital system segment.
The engagement resolved a disagreement argued from incomplete and conflicting anecdotal evidence, replacing it with a segmented, market-wide understanding of purchasing behaviour.
Impact
- Market research confirmed procedure categories with established robotic competitors showed meaningfully slower new-entrant success
- Hospital purchasing research revealed a segmentation by hospital system size that neither internal team had previously considered
- Competitive mapping identified two procedure categories combining strong demand growth with limited entrenched robotic competition
- Reimbursement research confirmed established pathways for both identified categories, removing a significant source of internal uncertainty
- The resolved investment strategy ended a leadership disagreement that had been delaying clinical trial design and regulatory planning
- The board approved concentrated investment in the two identified procedure categories within weeks of strategy delivery
- The first procedure-specific clinical evidence programme launched within four months of the engagement’s conclusion
- The existing platform’s broader capability was preserved as a longer-term asset rather than abandoned, satisfying both sides of the original debate
Client Outcome
Strategic Resolution
A prolonged leadership disagreement over platform versus procedure-specific investment was resolved with market-wide evidence rather than continued anecdotal advocacy.
Investment Concentration
Clinical and regulatory investment was concentrated in two procedure categories combining strong demand growth with limited entrenched competition.
Segmentation Insight
A hospital system size segmentation explained why internal teams had been citing genuinely different but equally valid customer evidence.
Clinical Programme Launch
The first procedure-specific clinical evidence programme launched within four months, ending a period of delayed decision-making.
Reimbursement Confidence
Established reimbursement pathways for both target procedure categories removed a significant source of board uncertainty.
Platform Preservation
The existing platform's broader capability was retained as a long-term asset, avoiding the false choice the original internal debate had implied.
Commercial Differentiation
Concentrated investment in genuinely accessible procedure categories positioned the company to build clinical evidence depth competitors had not yet established.
Leadership Alignment
Engineering, clinical, and commercial leadership reached shared strategic direction for the first time, grounded in market evidence rather than competing internal narratives.
Market Positioning
The client was repositioned as a strategically focused surgical robotics company investing where evidence showed genuine competitive opportunity existed.
Case Studies
Learn how our success stories power data-driven growth across industries
Platform or Procedure: How a Surgical Robotics Company Used Market Research and Strategy Advisory to Resolve Its Most Consequential Product Strategy Decision
Executive Snapshot Client Surgical Robotics Systems Developer, United States &...
Read MoreThe Acquisition Question: How a Regional Hospital Network Used Bespoke Research and Consulting to Decide Whether to Build, Lease, or Skip Orthopedic Robotic Capability
Executive Snapshot Client Regional Hospital Network, Midwestern United States Situation/Challenge...
Read MoreFrom Pilot to Purchase: How a Rehabilitation Robotics Manufacturer Used IDIs and Usage Analytics to Understand Why Successful Clinical Pilots Were Not Converting to Paid Adoption
Executive Snapshot Client Rehabilitation Robotics Device Manufacturer, North America &...
Read More